VivoSim Labs
VIVS
78 hedge funds and large institutions have $16.3M invested in VivoSim Labs in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 31 reducing their positions, and 20 closing their positions.
0.02% more ownership
Funds ownership: 0.18% → 0.2% (+0.02%)
16% less funds holding
Funds holding: 93 → 78 (-15)
25% less call options, than puts
Call options by funds: $6K | Put options by funds: $8K
45% less capital invested
Capital invested by funds: $29.8M → $16.3M (-$13.5M)
68% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 31
75% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$3.05M |
| 2 |
NAMA
Nikko Asset Management Americas
New York
|
+$668K |
| 3 |
Renaissance Technologies
New York
|
+$388K |
| 4 |
WG
Winton Group
London,
United Kingdom
|
+$164K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$32.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$766K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$295K |
| 3 |
Goldman Sachs
New York
|
-$226K |
| 4 |
Millennium Management
New York
|
-$218K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$213K |
VIVS Hedge Fund Activity: Q3 2019 in Review
78 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q3 2019, worth a combined $16.3M — down 45% from $29.8M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of VIVS and 5 opened new positions — a net loss of 15 holders — while 31 trimmed existing stakes and 10 added.
The largest buyer was Sumitomo Mitsui Trust Group, adding an estimated $3.05M. The largest seller was ARK Investment Management, cutting an estimated $766K.
- 78 institutional investors held VivoSim Labs (VIVS) as of Q3 2019, down from 93 in Q2 2019.
- Funds reported $16.3M of VivoSim Labs stock for Q3 2019, down 45% quarter-over-quarter.
- 5 funds opened new VivoSim Labs positions in Q3 2019 and 20 closed out, a net change of -15 holders.
- The largest VivoSim Labs buyer in Q3 2019 was Sumitomo Mitsui Trust Group, an estimated $3.05M added.
- The largest VivoSim Labs seller in Q3 2019 was ARK Investment Management, an estimated $766K sold.
Based on aggregated 13F filings for Q3 2019.